Anabolic Warfare Nuclear Armageddon


Notify me when this product is available:

Anabolic Warfare Nuclear Armageddon

Anabolic Warfare Nuclear Armageddon lives up to its name and then some! The perfect combination of energy and performance. Loaded with a mega-dose of caffeine for extreme focus and stable energy. Additional ingredients to help boost mood & sense of well-being. Packed with pump activators to improve blood flow, delivering crazy pumps!


Anabolic Warfare Nuclear Armageddon Benefits:
  • Unmatched energy
  • Sharp focus and drive
  • Insane blood flow, crazy vascularity, & PUMPS
  • Boost in performance and strength
  • Unmatched nutrient absorption
  • Elevated mood and sense of well-being


Anabolic Warfare Nuclear Armageddon Ingredient Breakdown:

Citrulline Malate - boosts blood flow and nitric oxide

Betaine Anhydrous ­ - improves strength output and overall performance

Beta Alanine – lessens muscle fatigue

L-Arginine – stimulates circulation and nutrient absorption  

Caffeine –for intense, yet stable energy

Rauwolscine - improves physical performance and aids in fat loss


Customers Also Love:

Anabolic Warfare Pump-N-Grind

Anabolic Warfare Maniac Pre-Workout

Anabolic Warfare Veiniac

Anabolic Warfare Liver Guardian

Anabolic Warfare PCT



Figueroa, Arturo et al. “Influence of L-citrulline and watermelon supplementation on vascular function and exercise performance.” Current opinion in clinical nutrition and metabolic care vol. 20,1 (2017): 92-98. doi:10.1097/MCO.0000000000000340

Hobson, R M et al. “Effects of β-alanine supplementation on exercise performance: a meta-analysis.” Amino acids vol. 43,1 (2012): 25-37. doi:10.1007/s00726-011-1200-z

Morris, Sidney M Jr. “Arginine Metabolism Revisited.” The Journal of nutrition vol. 146,12 (2016): 2579S-2586S. doi:10.3945/jn.115.226621

Pickering, Craig, and Jozo Grgic. “Caffeine and Exercise: What Next?.” Sports medicine (Auckland, N.Z.) vol. 49,7 (2019): 1007-1030. doi:10.1007/s40279-019-01101-0

Tam, S W et al. “Yohimbine: a clinical review.” Pharmacology & therapeutics vol. 91,3 (2001): 215-43. doi:10.1016/s0163-7258(01)00156-5